Is CVE-2014-5431 actively exploited?

No active exploitation of CVE-2014-5431 has been confirmed so far. Continue monitoring, as exploit status can change.

Can CVE-2014-5431 be exploited remotely?

No. CVE-2014-5431 requires physical access to exploit.

What is the CVSS score of CVE-2014-5431?

CVE-2014-5431 has a CVSS score of 6.8 (MEDIUM).

HOME VULNERABILITIESCVE-2014-5431

MEDIUM

CVE-2014-5431

CWE-259Published: March 26, 2019· Updated: Jun 17, 2026

6.8

CVSS v3.1

Official Description

Baxter SIGMA Spectrum Infusion System version 6.05 (model 35700BAX) with wireless battery module (WBM) version 16 contains a hard-coded password, which provides access to basic biomedical information, limited device settings, and network configuration of the WBM, if connected. The hard-coded password may allow an attacker with physical access to the device to access management functions to make unauthorized configuration changes to biomedical settings such as turn on and off wireless connections and the phase-complete audible alarm that indicates the end of an infusion phase. Baxter has released a new version of the SIGMA Spectrum Infusion System, version 8, which incorporates hardware and software changes.

NVD Source

Technical Analysis

CVE-2014-5431 requires local access, meaning attackers must already have a foothold on the target system.

The vulnerability requires no privileges and no user interaction, making it a prime target for automated exploitation campaigns and worm-like propagation.

A successful exploit results in complete confidentiality breach (data exposure), full integrity compromise (data manipulation), availability disruption (denial of service), with a CVSS base score of 6.8.